The assessment of synaptic dysfunction in neurodegenerative disorders by a novel single molecular array for Neuronal pentraxin 2
Mathias Sauer, Bárbara Fernandes Gomes, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, Olivia Belbin, Daniel Alcolea, Juan Fortea, Oskar Hansson, Johanna Nilsson, Nicholas J. Ashton · 2025
Read The assessment of synaptic dysfunction in neurodegenerative disorders by a novel single molecular array for Neuronal pentraxin 2 by Mathias Sauer, Bárbara Fernandes Gomes, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, Olivia Belbin, Daniel Alcolea, Juan Fortea, Oskar Hansson, Johanna Nilsson, Nicholas J. Ashton (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712579.txt.
Description
Mathias Sauer and co-authors build a new test for a synaptic protein that fades in brain degeneration. Their twenty twenty-five paper measures neuronal pentraxin 2 in spinal fluid. The protein supports synaptic plasticity, and its drop tracks thought decline.
Mass spectrometry can read it, but that gear is too scarce for wide clinic use. The team built a single-molecule array test that works with a tiny fluid sample. Shop antibodies were checked for the home-built assay. The test was then run in an Alzheimer disease group. A simpler, sensitive assay could bring synaptic health checks into routine memory clinic work, where they are now rare.
Catalog record
| CREATOR | Mathias Sauer, Bárbara Fernandes Gomes, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, Olivia Belbin, Daniel Alcolea, Juan Fortea, Oskar Hansson, Johanna Nilsson, Nicholas J. Ashton |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |